Yahoo
NasdaqGS - Delayed Quote USD

Ultragenyx Pharmaceutical Inc. (RARE)

15.30 +0.45 (+3.03%)
At close: September 4 at 4:00:00 PM EDT
15.38 +0.08 (+0.52%)
After hours: September 4 at 7:59:31 PM EDT
Trade RARE on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
717,000
673,000
560,000
434,000
363,329
Cost of Revenue
121,000
109,000
77,000
45,000
28,320
Gross Profit
596,000
564,000
483,000
389,000
335,009
Operating Expense
1,124,000
1,099,000
1,019,000
958,000
983,928
Operating Income
-528,000
-535,000
-536,000
-569,000
-648,919
Net Non Operating Interest Income Expense
-54,000
-37,000
-26,000
-39,000
-31,941
Other Income Expense
0
1,000
-5,000
-1,000
-20,865
Pretax Income
-582,000
-571,000
-567,000
-609,000
-701,725
Tax Provision
4,000
4,000
2,000
-2,000
5,696
Net Income Common Stockholders
-586,000
-575,000
-569,000
-607,000
-707,421
Diluted NI Available to Com Stockholders
-586,000
-575,000
-569,000
-607,000
-707,421
Basic EPS
-5.83
-5.83
-6.29
-8.25
-10.12
Diluted EPS
-5.83
-5.83
-6.29
-8.25
-10.12
Basic Average Shares
100,550
98,600
90,538.12
73,543.86
69,914.23
Diluted Average Shares
100,550
98,600
90,538.12
73,543.86
69,914.23
Total Operating Income as Reported
-528,000
-535,000
-536,000
-569,000
-648,919
Total Expenses
1,245,000
1,208,000
1,096,000
1,003,000
1,012,248
Net Income from Continuing & Discontinued Operation
-586,000
-575,000
-569,000
-607,000
-707,421
Normalized Income
-586,000
-575,000
-569,000
-607,000
-692,174.79
Interest Income
23,000
25,000
37,000
27,000
11,074
Interest Expense
77,000
62,000
63,000
66,000
43,015
Net Interest Income
-54,000
-37,000
-26,000
-39,000
-31,941
EBIT
-505,000
-509,000
-504,000
-543,000
-658,710
EBITDA
-472,000
-474,000
-468,000
-517,000
-640,490
Reconciled Cost of Revenue
121,000
109,000
77,000
45,000
28,320
Reconciled Depreciation
33,000
35,000
36,000
26,000
18,220
Net Income from Continuing Operation Net Minority Interest
-586,000
-575,000
-569,000
-607,000
-707,421
Total Unusual Items Excluding Goodwill
-1,036
--
-1,115
397
-19,299
Total Unusual Items
-1,036
--
-1,115
397
-19,299
Normalized EBITDA
-472,000
-474,000
-468,000
-517,000
-621,191
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-4,052.79
12/31/2022 - 1/31/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: